KeyBanc analyst Ken Newman raised the firm’s price target on Emerson (EMR) to $140 from $125 and keeps an Overweight rating on the shares. The firm notes shares outperformed following the company’s Q4 results and announcement of portfolio transformation actions. Management noted FY24 growth was driven by Process and Hybrid businesses, offset by ongoing weakness in Discrete end markets. That said, Discrete orders inflected positively in Q4 and KeyBanc was encouraged by management’s comments that these end markets have likely bottomed.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $125 from $118 at Baird
- Emerson price target raised to $135 from $128 at Wells Fargo
- Emerson price target raised to $116 from $103 at Barclays
- Emerson Electric Reports Strong 2024 Financial Results
- Aspen Technology confirms receipt of unsolicited takeover proposal from Emerson